GGGary M. Glazer

Gary M. Glazer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gary M. Glazer has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Creating a Patient-Centered Imaging Service: Determining What Patients Want

    by Pat A. Basu, Julie A. Ruiz-Wibbelsmann, Susan B. Spielman, Volney F. Van Dalsem, Jarrett K. Rosenberg, Gary M. Glazer

    OBJECTIVE. The purpose of this study is to determine patients' preferences for how, from whom, and how soon they receive imaging results.MATERIALS AND METHODS. Hard copies of our survey were randomly distributed to patients at an academic medical center outpatient imaging facility for 9 weeks, during August through October 2008, to collect data regarding patient preferences for how they received results (“Method”), from whom (“Person”), and how quickly (“Speed”).RESULTS. A total of 129 (23%) of 557 patients (47.4% male; median age, 55 years) undergoing CT (62%) and MRI (38%) completed the survey. According to survey responses, results needed to be communicated within a few hours for an “acceptable” rating from 95% of patients. Thirty-one percent preferred to receive normal results by the fastest method, whereas 35% preferred to receive abnormal results by telephone. Patients did not show an overwhelming preference regarding which physician communicates the results. More than 25% of patients were indiffere...


  • The Invisible Radiologist

    by Gary M. Glazer, Julie A. Ruiz-Wibbelsmann


  • Open Access

    A strategy for blood biomarker amplification and localization using ultrasound

    by Aloma L. D'SOuza, Jeffrey R. Tseng, Kim Butts Pauly, Samira Guccione, Jarrett Rosenberg, Sanjiv S. Gambhir, Gary M. Glazer

    Blood biomarkers have significant potential applications in early detection and management of various diseases, including cancer. Most biomarkers are present in low concentrations in blood and are difficult to discriminate from noise. Furthermore, blood measurements of a biomarker do not provide information about the location(s) where it is produced. We hypothesize a previously undescribed strategy to increase the concentration of biomarkers in blood as well as localize the source of biomarker signal using ultrasound energy directly applied to tumor cells. We test and validate our hypothesis in cell culture experiments and mouse tumor xenograft models using the human colon cancer cell line LS174T, while measuring the biomarker carcinoembryonic antigen (CEA) before and after the use of ultrasound to liberate the biomarker from the tumor cells. The results demonstrate that the application of low-frequency ultrasound to tumor cells causes a significant release of tumor biomarker, which can be measured in the blood. Furthermore, we establish that this release is specific to the direct application of the ultrasound to the tumor, enabling a method for localization of biomarker production. This work shows that it is possible to use ultrasound to amplify and localize the source of CEA levels in blood of tumor-bearing mice and will allow for a previously undescribed way to determine the presence and localization of disease more accurately using a relatively simple and noninvasive strategy.